PRKAA2 and neoplasm: These findings are consistent with the view that, while AMPK-α2 is a tumour suppressor in that tumour growth is accelerated when it is lost, AMPK-α1 is a tumour promoter whose presence is required for the growth of cancer cells in vivo.